ALLIE-HMG 150 IU is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ALLIE-HMG 150 IU |
|---|---|
| Composition | Menotropin Injection 150 IU |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | 150 IU |
| Country of Origin | India |
Menotropin Injection 150 IU (Menotropin Injection 150 IU) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ALLIE-HMG 150 IU (Menotropin Injection 150 IU) is a hormonal fertility medicine used in the treatment of infertility in both women and men. It contains Menotropin, also known as Human Menopausal Gonadotropin (HMG), which is a combination of two important reproductive hormones — Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). These hormones play a major role in supporting ovulation in women and sperm production in men.
ALLIE-HMG 150 IU is widely used in fertility treatment programs, IVF procedures, assisted reproductive technology (ART), ovulation induction therapy, and male infertility management. This injection helps stimulate healthy ovarian follicle development in women and supports sperm production in men who have hormonal deficiencies affecting fertility.
Infertility can affect both men and women due to hormonal imbalance, ovulation disorders, low sperm production, or reproductive health complications. Fertility medicines like Menotropin Injection are commonly prescribed by gynecologists, fertility specialists, and infertility experts to improve the chances of conception and reproductive success.
In women, ALLIE-HMG 150 IU works by stimulating the ovaries to produce mature eggs. It is commonly recommended for women who are unable to ovulate properly or who are undergoing fertility procedures such as:
• In Vitro Fertilization (IVF)
• Intrauterine Insemination (IUI)
• Assisted Reproductive Technology (ART)
• Ovulation induction treatment
In men, Menotropin helps stimulate testosterone activity and sperm production, especially in patients with hormonal disorders such as hypogonadotropic hypogonadism and low sperm count.
ALLIE-HMG 150 IU is manufactured under strict pharmaceutical quality standards to ensure safety, effectiveness, and reliable therapeutic performance. The medicine is intended for use only under medical supervision and should be administered by trained healthcare professionals or fertility specialists.
This hormonal injection is commonly used in fertility clinics, IVF centers, gynecology hospitals, and reproductive health treatment programs. Patients undergoing fertility therapy may require regular monitoring through ultrasound scans, hormone testing, and medical evaluation to improve treatment outcomes and reduce complications.
Because fertility treatment plans vary from patient to patient, doctors carefully determine the dosage and treatment schedule depending on age, hormonal condition, reproductive health, and response to treatment.
ALLIE-HMG 150 IU has become an important medicine in modern infertility management due to its effectiveness in supporting reproductive hormone balance and improving fertility treatment success rates.
ALLIE-HMG 150 IU (Menotropin Injection 150 IU) is mainly used in fertility treatment and reproductive health management for both women and men.
ALLIE-HMG 150 IU is commonly used in women who are facing difficulty conceiving due to ovulation-related problems or hormonal imbalance.
The injection helps stimulate ovulation by encouraging the ovaries to produce and release mature eggs.
Menotropin Injection is widely used during In Vitro Fertilization (IVF) treatment cycles to support controlled ovarian stimulation.
The medicine plays an important role in modern fertility treatment procedures such as:
• IVF
• IUI
• ART protocols
Doctors may prescribe ALLIE-HMG 150 IU for women with ovulation problems related to PCOS.
The injection helps improve healthy ovarian follicle growth during fertility treatment cycles.
ALLIE-HMG 150 IU is also used in men with hormonal fertility problems and reduced sperm production.
The medicine helps support spermatogenesis and improve sperm production in eligible patients.
Doctors may recommend Menotropin therapy for men with hormone-related reproductive disorders affecting fertility.
The medicine helps improve hormonal stimulation required for reproductive function and fertility management.
Menotropin contains two important reproductive hormones:
• Follicle Stimulating Hormone (FSH)
• Luteinizing Hormone (LH)
These hormones naturally help regulate fertility and reproductive function.
ALLIE-HMG 150 IU works by:
• Stimulating ovarian follicles
• Supporting egg maturation
• Helping ovulation
• Improving fertility treatment response
The injection works by:
• Stimulating sperm production
• Supporting reproductive hormone activity
• Helping improve fertility-related hormonal balance
This hormonal mechanism helps fertility specialists manage infertility treatment more effectively.
Like other fertility medicines, ALLIE-HMG 150 IU may cause side effects in some patients. Side effects may vary depending on hormonal response, treatment duration, dosage, and overall health condition.
Mild to moderate headaches may occur during fertility treatment.
Some women may experience stomach discomfort or bloating due to ovarian stimulation.
Digestive discomfort or nausea may occur in certain patients.
Pain, redness, swelling, or irritation at the injection site may develop.
Hormonal changes may cause breast discomfort or tenderness.
Some patients may feel tired or low in energy during treatment.
Hormonal fertility medicines may occasionally affect mood or emotional balance.
Women undergoing ovulation induction may experience mild pelvic pain or pressure.
Certain rare side effects may require immediate medical attention.
• Severe abdominal pain
• Rapid weight gain
• Difficulty breathing
• Severe allergic reactions
• Ovarian Hyperstimulation Syndrome (OHSS)
• Severe pelvic swelling
• Chest pain
• Unusual bleeding
Patients should immediately contact their doctor if severe symptoms develop during fertility treatment.
The dosage of ALLIE-HMG 150 IU (Menotropin Injection 150 IU) should always be determined by a qualified fertility specialist or healthcare professional.
Dosage may vary depending on whether the treatment is for female infertility, ovulation induction, IVF support, or male infertility.
Doctors evaluate hormone levels before starting treatment.
The patient’s age and reproductive condition play an important role in dosage planning.
Dosage adjustments may be made based on follicular development, ovulation response, or sperm production results.
Patients undergoing IVF or ART procedures may require individualized dosing schedules.
ALLIE-HMG 150 IU is administered:
• By subcutaneous (SC) injection
• Or intramuscular (IM) injection
• Under medical supervision
• By trained healthcare professionals or fertility specialists
Patients should never self-administer the medicine without proper medical guidance.
• Follow the doctor’s fertility treatment schedule carefully
• Regular ultrasound monitoring may be required
• Hormone testing may be necessary during therapy
• Do not skip doses
• Inform your doctor about side effects immediately
• Avoid changing dosage without medical advice
Before starting treatment, patients should inform their doctor if they have:
• Thyroid disorders
• Ovarian cysts
• Hormonal disorders
• Liver disease
• Kidney disease
• Reproductive organ tumors
• Previous fertility treatment complications
Women who are pregnant should not use this medicine unless specifically recommended by a healthcare professional.
• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from direct sunlight
• Keep out of reach of children
• Store under recommended medical conditions
• High-quality fertility hormone formulation
• Trusted infertility treatment support
• Effective ovarian stimulation therapy
• Supports IVF and ART procedures
• Manufactured under strict pharmaceutical standards
• Reliable reproductive hormone therapy
• Suitable for modern fertility treatment protocols
It is mainly used for fertility treatment, ovulation induction, IVF support, and management of male and female infertility.
Menotropin is a hormonal medicine containing FSH and LH hormones used in fertility treatment programs.
Yes, it is commonly used in IVF and assisted reproductive technology procedures.
Yes, doctors may prescribe it for male infertility and low sperm production related to hormonal deficiency.
Yes, fertility specialists usually recommend ultrasound scans and hormone tests during treatment.
In rare cases, ovarian hyperstimulation syndrome (OHSS) may occur and requires medical attention.
Yes, this medicine should always be used under the supervision of qualified fertility specialists or healthcare professionals.
Patients should only use the injection exactly as instructed by their doctor or fertility specialist.